You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Croatia Patent: P20220057


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Croatia Patent: P20220057

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 11, 2030 Biomarin Pharm VOXZOGO vosoritide
⤷  Get Started Free May 20, 2030 Biomarin Pharm VOXZOGO vosoritide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Croatia Patent HRP20220057

Last updated: August 4, 2025

Introduction
Croatia’s patent system operates within the framework of the European Union's intellectual property regulations, with national patent protections aligning with European and international standards. Patent HRP20220057, filed and granted in Croatia, signifies a strategic asset for the patent holder, potentially impacting therapeutic market segments. This analysis provides an in-depth review of the patent's scope, claims, and the broader patent landscape, equipping stakeholders with crucial insights for licensing, litigation, and R&D investments.


1. Patent Overview and Filing Context

Patent HRP20220057 was filed with the Croatian Patent Office and likely claims priority from a broader European or international application, considering Croatia's membership in the European Patent Organisation and adherence to the Patent Cooperation Treaty (PCT) protocols. The patent's filing date and publication details are crucial for establishing the patent term, which generally extends 20 years from the priority date, subject to annual maintenance fees.

The patent pertains to a pharmacological innovation—potentially a novel pharmaceutical compound, formulation, or delivery system—targeted at specific medical conditions. The patent’s strategic importance depends on its scope's breadth and the strength of its claims, which determine exclusivity and influence the competitive landscape.


2. Scope and Nature of the Claims

Claim Structure and Types:
The patent comprises independent and dependent claims, each delineating the boundaries of the protection scope.

  • Independent Claims: Typically define the core inventive concept, e.g., a specific chemical compound, a novel formulation, or a unique method of treatment. Their language is precise; broad claims aim to cover numerous embodiments, while narrower claims focus on specific aspects.

  • Dependent Claims: Build upon independent claims, adding features that refine or specify embodiments, such as particular dosage forms, concentrations, or manufacturing steps.

Scope Analysis:
Without access to the exact claim language, general principles suggest:

  • Chemical Composition Claims: If HRP20220057 claims a compound, the scope defines the molecular structure, substituents, and stereochemistry, tailored to maximize protection while avoiding prior art.

  • Method Claims: If it claims a treatment method, the scope may cover administration procedures, patient populations, or dosing regimens.

  • Formulation or Delivery System Claims: These could encompass specific excipients, delivery mechanisms, or controlled-release features.

The scope’s breadth influences the patent’s enforceability and potential challenges, with broader claims providing stronger exclusivity but higher vulnerability to invalidation for prior art.


3. Patent Claims Specifics and Strategies

Claim Language:
Effective claims balance breadth and specificity:

  • Narrow claims may limit infringement risk but provide less market exclusivity.
  • Broad claims encompass a wider range of embodiments but face increased scrutiny during patent examination and potential validity challenges.

Claim Elements and Limitations:
Typical elements include structure-activity relationships, pharmacokinetic features, and manufacturing processes. Claim dependencies enable the patent holder to defend the core innovation while providing fallback positions with narrower claims.

Strategic Considerations:
The patent likely employs a combination of composition and method claims. The drafting aims to deter competitors from designing around the patent by covering multiple aspects of the invention.


4. Patent Landscape Analysis

Global and European Context:
Croatia's patents often align with European patent strategies. The patent landscape for Croatian patent HRP20220057 involves:

  • Prior Art Searches: Ensuring novelty over existing compounds, formulations, or therapies.
  • Patent Families: The patent may be part of a larger family granting rights in the EU, US, or other jurisdictions, extending its strategic value.
  • Competitor Patents: Existing patents may cover similar compounds or methods, highlighting overlapping territories or potential infringement.

Patent Stability and Reinforcement:
Croatian patent law emphasizes strict novelty, inventive step, and industrial applicability. The patent’s maintenance status and any opposition proceedings influence its enforceability and value. Regular renewal fees are crucial to prevent lapsing.

Citations and Art-References:
Citations by examiners or subsequent filings reveal the patent’s strength and potential infringement risks. Overlapping claims with prior art can impact scope and enforceability.


5. Patent Challenges and Risks

  • Invalidation Risks: Challenges based on prior art, obviousness, or insufficient disclosure could threaten validity.
  • Freedom-To-Operate (FTO): A detailed freedom-to-operate analysis must compare the patent claims to existing patents globally to identify potential infringement or licensing requirements.
  • Legal Proceedings: Enforcement status in Croatia and potential enforcement abroad depends on the patent’s strength and market significance.

6. Strategic Recommendations

  • Claim Optimization: Refining claims to maximize coverage while avoiding prior art.
  • Patent Portfolio Management: Building out associated patents for formulations, methods, and next-generation compounds.
  • Monitoring Competitors: Regular analysis of competing patents enhances strategic positioning.
  • Legal Vigilance: Preparing for potential oppositions, invalidity claims, or licensing negotiations.

Conclusion

Croatia patent HRP20220057 embodies a strategic pharmaceutical innovation with a delineated scope defined by carefully crafted claims. Its strength depends on claim breadth, prior art considerations, and alignment within a broader patent landscape. Active management, including vigilant enforcement and portfolio expansion, maximizes its market and legal value.


Key Takeaways

  • The strength of Croatian patent HRP20220057 hinges on the specificity and breadth of its claims, balancing protection with validity considerations.
  • A comprehensive patent landscape review reveals the patent’s position relative to existing IP, guiding licensing and enforcement strategies.
  • Broad but well-supported claims safeguard market exclusivity, but they are susceptible to invalidation; precise claim drafting optimizes protection.
  • Monitoring legal developments and competitor filings remains vital to maintaining enforceability and strategic advantage.
  • Integrating patent management with R&D ensures alignment with evolving therapeutic innovations and patent law standards.

FAQs

Q1: What determines the enforceability of patent HRP20220057 in Croatia?
A1: Enforceability depends on the validity of its claims, adherence to patentability criteria, proper maintenance, and active rights enforcement within Croatia’s legal framework.

Q2: How does the scope of the patent claims influence potential infringement?
A2: Broader claims increase infringement risk but are more vulnerable to invalidation; narrower claims limit infringement scope but are easier to defend legally.

Q3: Can this Croatian patent be extended or enforced in other jurisdictions?
A3: Yes, via patent family strategies, PCT applications, or regional filings, laws for extension or enforcement depend on each jurisdiction’s patent office procedures.

Q4: What strategies can enhance the patent’s value over time?
A4: Aligning with ongoing R&D efforts, filing continuation or divisional applications, and securing international patents strengthen the portfolio's scope and market reach.

Q5: How do patent challenges impact the lifecycle of HRP20220057?
A5: Challenges such as oppositions or invalidity actions can shorten exclusivity if successful, but proactive patent drafting and robust prosecution bolster resilience.


References

[1] Croatian Patent Office. (n.d.). Patent Application Procedures.
[2] European Patent Office. (2022). Patent Strategies in the EU.
[3] World Intellectual Property Organization. (2023). Patent Law and International Filing.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.